mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.2 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.3 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.3 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.3 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |